Trials / Completed
CompletedNCT02121054
Research of Resistance to Antiplatelet Agents and Development of Tailored Treatment Model for Patients With Coronary Artery Disease
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 1,527 (actual)
- Sponsor
- Young-Hak Kim, MD, PhD · Academic / Other
- Sex
- All
- Age
- 20 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to evaluate the prognosis of patients with resistance to antiplatelet agent and develop tailored treatment model for patients with coronary artery disease.
Conditions
Timeline
- Start date
- 2013-10-19
- Primary completion
- 2020-10-29
- Completion
- 2020-10-29
- First posted
- 2014-04-23
- Last updated
- 2023-03-20
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT02121054. Inclusion in this directory is not an endorsement.